ViiV Healthcare
Part of GSK
CompanyUnited KingdomFounded 2009
ViiV Healthcare develops one asset, approved (dolutegravir in HIV infection). Mostly small molecule; based in the United Kingdom, founded in 2009.
- 1
- Asset
- Furthest stage
- Approved
- 47
- Trials
- 0
- Signals
Pipeline
1HIV integrase strand transfer inhibitor preventing viral DNA integration into host genome.
Approved, Small molecule, HIV infection, HIV-1 infection
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials85
- Similar companies6